The patients with gastrointestinal neoplasms within the indication of endoscopic submucosal dissection (ESD) and has been on antiplatelet therapy.
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients on antiplatelet therapy who will undergo ESD of gastrointestinal neoplasms and have given written informed consent to this study.
Exclusion criteria
Exclusion criteria: Those who have serious complications. Those who are considered to be inappropriate for this study by doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the rate of delayed bleeding intraoperative bleeding | — |
Countries
Japan
Contacts
Nagasaki University Hospital Department of Endoscopy